A Breath of Fresh Career

A Breath of Fresh Career S2, E4 (Jason Meyenburg CEO, Gemini Therapeutics)

Justin Kane Season 2 Episode 4

This episode of A Breath of Fresh Career features Jason Meyneburg the CEO of Gemini Therapeutics. Gemini Therapeutics is a precision medicine company focused on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases. Our therapeutic candidates are matched to molecular abnormalities found in patients with high clinical need and our broad multimodal pipeline includes monoclonal antibodies, recombinant proteins, and gene therapies. Launched with funding from leading life science investors and powered by academic partnerships around the world, we are developing a series of first-in-class therapeutics. For more information, visit www.GeminiTherapeutics.com.

Jason discusses his role as CEO, how he got his start in the Biotech industry, his advice on taking Gemini public through a SPAC, and general advice on how to stand out as a candidate.

Connect with him here:

https://www.linkedin.com/in/jasonmeyenburg/ 

https://twitter.com/gemini_thera 

https://www.linkedin.com/company/geminitherapeutics/about/